-
1
-
-
79952717349
-
An official ATS/ERS/ JRS/ALAT statement: Idiopathic pulmonary fibrosis: Evidence-based guidelines for diagnosis and management
-
Raghu G, Collard HR, Egan JJ, Martinez FJ, Behr J, Brown KK, Colby TV, Cordier JF, Flaherty KR, Lasky JA, et al .; ATS/ERS/JRS/ALAT Committee on Idiopathic Pulmonary Fibrosis. An official ATS/ERS/ JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med 2011;183:788-824.
-
(2011)
Am J Respir Crit Care Med
, vol.183
, pp. 788-824
-
-
Raghu, G.1
Collard, H.R.2
Egan, J.J.3
Martinez, F.J.4
Behr, J.5
Brown, K.K.6
Colby, T.V.7
Cordier, J.F.8
Flaherty, K.R.9
Lasky, J.A.10
-
2
-
-
33749444308
-
Incidence and prevalence of idiopathic pulmonary fibrosis
-
Raghu G, Weycker D, Edelsberg J, Bradford WZ, Oster G. Incidence and prevalence of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2006;174:810-816.
-
(2006)
Am J Respir Crit Care Med
, vol.174
, pp. 810-816
-
-
Raghu, G.1
Weycker, D.2
Edelsberg, J.3
Bradford, W.Z.4
Oster, G.5
-
3
-
-
22044432630
-
Health-related quality of life in patients with idiopathic pulmonary fibrosis: A systematic review
-
Swigris JJ, Kuschner WG, Jacobs SS, Wilson SR, Gould MK. Health-related quality of life in patients with idiopathic pulmonary fibrosis: a systematic review. Thorax 2005;60:588-594.
-
(2005)
Thorax
, vol.60
, pp. 588-594
-
-
Swigris, J.J.1
Kuschner, W.G.2
Jacobs, S.S.3
Wilson, S.R.4
Gould, M.K.5
-
4
-
-
84901810710
-
Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis
-
Richeldi L, du Bois RM, Raghu G, Azuma A, Brown KK, Costabel U, Cottin V, Flaherty KR, Hansell DM, Inoue Y, et al .; INPULSIS Trial Investigators. Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis. N Engl J Med 2014;370:2071-2082.
-
(2014)
N Engl J Med
, vol.370
, pp. 2071-2082
-
-
Richeldi, L.1
Du Bois, R.M.2
Raghu, G.3
Azuma, A.4
Brown, K.K.5
Costabel, U.6
Cottin, V.7
Flaherty, K.R.8
Hansell, D.M.9
Inoue, Y.10
-
5
-
-
84901759236
-
A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis
-
King TE Jr, Bradford WZ, Castro-Bernardini S, Fagan EA, Glaspole I, Glassberg MK, Gorina E, Hopkins PM, Kardatzke D, Lancaster L, et al.; ASCEND Study Group. A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis. N Engl J Med 2014;370:2083-2092.
-
(2014)
N Engl J Med
, vol.370
, pp. 2083-2092
-
-
King, T.E.1
Bradford, W.Z.2
Castro-Bernardini, S.3
Fagan, E.A.4
Glaspole, I.5
Glassberg, M.K.6
Gorina, E.7
Hopkins, P.M.8
Kardatzke, D.9
Lancaster, L.10
-
7
-
-
0024822235
-
An immunohistochemical study of architectural remodeling and connective tissue synthesis in pulmonary fibrosis
-
Kuhn C III, Boldt J, King TE Jr, Crouch E, Vartio T, McDonald JA. An immunohistochemical study of architectural remodeling and connective tissue synthesis in pulmonary fibrosis. Am Rev Respir Dis 1989;140:1693-1703.
-
(1989)
Am Rev Respir Dis
, vol.140
, pp. 1693-1703
-
-
Kuhn, C.1
Boldt, J.2
King, T.E.3
Crouch, E.4
Vartio, T.5
McDonald, J.A.6
-
8
-
-
0022518573
-
Intraluminal fibrosis in interstitial lung disorders
-
Basset F, Ferrans VJ, Soler P, Takemura T, Fukuda Y, Crystal RG. Intraluminal fibrosis in interstitial lung disorders. Am J Pathol 1986;122:443-461.
-
(1986)
Am J Pathol
, vol.122
, pp. 443-461
-
-
Basset, F.1
Ferrans, V.J.2
Soler, P.3
Takemura, T.4
Fukuda, Y.5
Crystal, R.G.6
-
9
-
-
84899753316
-
Alveolar epithelium: Beyond the barrier
-
Borok Z. Alveolar epithelium: beyond the barrier. Am J Respir Cell Mol Biol 2014;50:853-856.
-
(2014)
Am J Respir Cell Mol Biol
, vol.50
, pp. 853-856
-
-
Borok, Z.1
-
10
-
-
84892643019
-
Future directions in idiopathic pulmonary fibrosis research. An NHLBI workshop report
-
Blackwell TS, Tager AM, Borok Z, Moore BB, Schwartz DA, Anstrom KJ, Bar-Joseph Z, Bitterman P, Blackburn MR, Bradford W, et al. Future directions in idiopathic pulmonary fibrosis research. An NHLBI workshop report. Am J Respir Crit Care Med 2014;189:214-222.
-
(2014)
Am J Respir Crit Care Med
, vol.189
, pp. 214-222
-
-
Blackwell, T.S.1
Tager, A.M.2
Borok, Z.3
Moore, B.B.4
Schwartz, D.A.5
Anstrom, K.J.6
Bar-Joseph, Z.7
Bitterman, P.8
Blackburn, M.R.9
Bradford, W.10
-
11
-
-
84877086317
-
Fibrosis of two: Epithelial cell-fibroblast interactions in pulmonary fibrosis
-
Sakai N, Tager AM. Fibrosis of two: epithelial cell-fibroblast interactions in pulmonary fibrosis. Biochim Biophys Acta 2013;1832:911-921.
-
(2013)
Biochim Biophys Acta
, vol.1832
, pp. 911-921
-
-
Sakai, N.1
Tager, A.M.2
-
12
-
-
33744924735
-
Role of epithelial cells in idiopathic pulmonary fibrosis: From innocent targets to serial killers
-
Selman M, Pardo A. Role of epithelial cells in idiopathic pulmonary fibrosis: from innocent targets to serial killers. Proc Am Thorac Soc 2006;3:364-372.
-
(2006)
Proc Am Thorac Soc
, vol.3
, pp. 364-372
-
-
Selman, M.1
Pardo, A.2
-
14
-
-
34548771370
-
Does current knowledge explain the pathogenesis of idiopathic pulmonary fibrosis? A perspective
-
Hunninghake GW, Schwarz MI. Does current knowledge explain the pathogenesis of idiopathic pulmonary fibrosis? A perspective. Proc Am Thorac Soc 2007;4:449-452.
-
(2007)
Proc Am Thorac Soc
, vol.4
, pp. 449-452
-
-
Hunninghake, G.W.1
Schwarz, M.I.2
-
15
-
-
84864740280
-
Pulmonary fibrosis: Patterns and perpetrators
-
Noble PW, Barkauskas CE, Jiang D. Pulmonary fibrosis: patterns and perpetrators. J Clin Invest 2012;122:2756-2762.
-
(2012)
J Clin Invest
, vol.122
, pp. 2756-2762
-
-
Noble, P.W.1
Barkauskas, C.E.2
Jiang, D.3
-
16
-
-
84878864199
-
The hallmarks of aging
-
López-Otín C, Blasco MA, Partridge L, Serrano M, Kroemer G. The hallmarks of aging. Cell 2013;153:1194-1217.
-
(2013)
Cell
, vol.153
, pp. 1194-1217
-
-
López-Otín, C.1
Blasco, M.A.2
Partridge, L.3
Serrano, M.4
Kroemer, G.5
-
17
-
-
84890558367
-
Mechanistic links between aging and lung fibrosis
-
Thannickal VJ. Mechanistic links between aging and lung fibrosis. Biogerontology 2013;14:609-615.
-
(2013)
Biogerontology
, vol.14
, pp. 609-615
-
-
Thannickal, V.J.1
-
18
-
-
84901022861
-
Revealing the pathogenic and aging-related mechanisms of the enigmatic idiopathic pulmonary fibrosis. An integral model
-
Selman M, Pardo A. Revealing the pathogenic and aging-related mechanisms of the enigmatic idiopathic pulmonary fibrosis. an integral model. Am J Respir Crit Care Med 2014;189:1161-1172.
-
(2014)
Am J Respir Crit Care Med
, vol.189
, pp. 1161-1172
-
-
Selman, M.1
Pardo, A.2
-
19
-
-
0036570052
-
Heterozygosity for a surfactant protein C gene mutation associated with usual interstitial pneumonitis and cellular nonspecific interstitial pneumonitis in one kindred
-
Thomas AQ, Lane K, Phillips J III, Prince M, Markin C, Speer M, Schwartz DA, Gaddipati R, Marney A, Johnson J, et al. Heterozygosity for a surfactant protein C gene mutation associated with usual interstitial pneumonitis and cellular nonspecific interstitial pneumonitis in one kindred. Am J Respir Crit Care Med 2002;165:1322-1328.
-
(2002)
Am J Respir Crit Care Med
, vol.165
, pp. 1322-1328
-
-
Thomas, A.Q.1
Lane, K.2
Phillips, J.3
Prince, M.4
Markin, C.5
Speer, M.6
Schwartz, D.A.7
Gaddipati, R.8
Marney, A.9
Johnson, J.10
-
20
-
-
8544245673
-
Genetic mutations in surfactant protein C are a rare cause of sporadic cases of IPF
-
Lawson WE, Grant SW, Ambrosini V, Womble KE, Dawson EP, Lane KB, Markin C, Renzoni E, Lympany P, Thomas AQ, et al . Genetic mutations in surfactant protein C are a rare cause of sporadic cases of IPF. Thorax 2004;59:977-980.
-
(2004)
Thorax
, vol.59
, pp. 977-980
-
-
Lawson, W.E.1
Grant, S.W.2
Ambrosini, V.3
Womble, K.E.4
Dawson, E.P.5
Lane, K.B.6
Markin, C.7
Renzoni, E.8
Lympany, P.9
Thomas, A.Q.10
-
21
-
-
58149159548
-
Genetic defects in surfactant protein A2 are associated with pulmonary fibrosis and lung cancer
-
Wang Y, Kuan PJ, Xing C, Cronkhite JT, Torres F, Rosenblatt RL, DiMaio JM, Kinch LN, Grishin NV, Garcia CK. Genetic defects in surfactant protein A2 are associated with pulmonary fibrosis and lung cancer. Am J Hum Genet 2009;84:52-59.
-
(2009)
Am J Hum Genet
, vol.84
, pp. 52-59
-
-
Wang, Y.1
Kuan, P.J.2
Xing, C.3
Cronkhite, J.T.4
Torres, F.5
Rosenblatt, R.L.6
DiMaio, J.M.7
Kinch, L.N.8
Grishin, N.V.9
Garcia, C.K.10
-
22
-
-
78649859428
-
Surfactant protein C mutations are the basis of a significant portion of adult familial pulmonary fibrosis in a Dutch cohort
-
van Moorsel CH, van Oosterhout MF, Barlo NP, de Jong PA, van der Vis JJ, Ruven HJ, van Es HW, van den Bosch JM, Grutters JC. Surfactant protein C mutations are the basis of a significant portion of adult familial pulmonary fibrosis in a Dutch cohort. Am J Respir Crit Care Med 2010;182:1419-1425.
-
(2010)
Am J Respir Crit Care Med
, vol.182
, pp. 1419-1425
-
-
Van Moorsel, C.H.1
Van Oosterhout, M.F.2
Barlo, N.P.3
De Jong, P.A.4
Van Der Vis, J.J.5
Ruven, H.J.6
Van Es, H.W.7
Van Den Bosch, J.M.8
Grutters, J.C.9
-
24
-
-
34047188508
-
Telomerase mutations in families with idiopathic pulmonary fibrosis
-
Armanios MY, Chen JJ, Cogan JD, Alder JK, Ingersoll RG, Markin C, Lawson WE, Xie M, Vulto I, Phillips JA III, et al. Telomerase mutations in families with idiopathic pulmonary fibrosis. N Engl J Med 2007;356:1317-1326.
-
(2007)
N Engl J Med
, vol.356
, pp. 1317-1326
-
-
Armanios, M.Y.1
Chen, J.J.2
Cogan, J.D.3
Alder, J.K.4
Ingersoll, R.G.5
Markin, C.6
Lawson, W.E.7
Xie, M.8
Vulto, I.9
Phillips, J.A.10
-
25
-
-
34250614359
-
Adult-onset pulmonary fibrosis caused by mutations in telomerase
-
Tsakiri KD, Cronkhite JT, Kuan PJ, Xing C, Raghu G, Weissler JC, Rosenblatt RL, Shay JW, Garcia CK. Adult-onset pulmonary fibrosis caused by mutations in telomerase. Proc Natl Acad Sci USA 2007;104:7552-7557.
-
(2007)
Proc Natl Acad Sci USA
, vol.104
, pp. 7552-7557
-
-
Tsakiri, K.D.1
Cronkhite, J.T.2
Kuan, P.J.3
Xing, C.4
Raghu, G.5
Weissler, J.C.6
Rosenblatt, R.L.7
Shay, J.W.8
Garcia, C.K.9
-
26
-
-
54049136464
-
A genome-wide association study identifies an association of a common variant in TERT with susceptibility to idiopathic pulmonary fibrosis
-
Mushiroda T, Wattanapokayakit S, Takahashi A, Nukiwa T, Kudoh S, Ogura T, Taniguchi H, Kubo M, Kamatani N, Nakamura Y; Pirfenidone Clinical Study Group. A genome-wide association study identifies an association of a common variant in TERT with susceptibility to idiopathic pulmonary fibrosis. J Med Genet 2008;45:654-656.
-
(2008)
J Med Genet
, vol.45
, pp. 654-656
-
-
Mushiroda, T.1
Wattanapokayakit, S.2
Takahashi, A.3
Nukiwa, T.4
Kudoh, S.5
Ogura, T.6
Taniguchi, H.7
Kubo, M.8
Kamatani, N.9
Nakamura, Y.10
-
27
-
-
18144398953
-
Pathways connecting telomeres and p53 in senescence, apoptosis, and cancer
-
Artandi SE, Attardi LD. Pathways connecting telomeres and p53 in senescence, apoptosis, and cancer. Biochem Biophys Res Commun 2005;331:881-890.
-
(2005)
Biochem Biophys Res Commun
, vol.331
, pp. 881-890
-
-
Artandi, S.E.1
Attardi, L.D.2
-
28
-
-
0022891340
-
Tumors: Wounds that do not heal. Similarities between tumor stroma generation and wound healing
-
Dvorak HF. Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. N Engl J Med 1986;315:1650-1659.
-
(1986)
N Engl J Med
, vol.315
, pp. 1650-1659
-
-
Dvorak, H.F.1
-
29
-
-
0035181198
-
Pulmonary (99m)Tc-DTPA aerosol clearance and survival in usual interstitial pneumonia (UIP)
-
Mogulkoc N, Brutsche MH, Bishop PW, Murby B, Greaves MS, Horrocks AW, Wilson M, McCullough C, Prescott M, Egan JJ; Greater Manchester Pulmonary Fibrosis Consortium. Pulmonary (99m)Tc-DTPA aerosol clearance and survival in usual interstitial pneumonia (UIP). Thorax 2001;56:916-923.
-
(2001)
Thorax
, vol.56
, pp. 916-923
-
-
Mogulkoc, N.1
Brutsche, M.H.2
Bishop, P.W.3
Murby, B.4
Greaves, M.S.5
Horrocks, A.W.6
Wilson, M.7
McCullough, C.8
Prescott, M.9
Egan, J.J.10
Greater Manchester Pulmonary Fibrosis Consortium11
-
30
-
-
58849094483
-
MMP expression and abnormal lung permeability are important determinants of outcome in IPF
-
McKeown S, Richter AG, O'Kane C, McAuley DF, Thickett DR. MMP expression and abnormal lung permeability are important determinants of outcome in IPF. Eur Respir J 2009;33:77-84.
-
(2009)
Eur Respir J
, vol.33
, pp. 77-84
-
-
McKeown, S.1
Richter, A.G.2
O'Kane, C.3
McAuley, D.F.4
Thickett, D.R.5
-
31
-
-
84893934829
-
Presence of a prothrombotic state in people with idiopathic pulmonary fibrosis: A population-based case-control study
-
Navaratnam V, Fogarty AW, McKeever T, Thompson N, Jenkins G, Johnson SR, Dolan G, Kumaran M, Pointon K, Hubbard RB. Presence of a prothrombotic state in people with idiopathic pulmonary fibrosis: a population-based case-control study. Thorax 2014;69:207-215.
-
(2014)
Thorax
, vol.69
, pp. 207-215
-
-
Navaratnam, V.1
Fogarty, A.W.2
McKeever, T.3
Thompson, N.4
Jenkins, G.5
Johnson, S.R.6
Dolan, G.7
Kumaran, M.8
Pointon, K.9
Hubbard, R.B.10
-
32
-
-
0033659495
-
Bleomycin-induced pulmonary fibrosis in fibrinogen-null mice
-
Hattori N, Degen JL, Sisson TH, Liu H, Moore BB, Pandrangi RG, Simon RH, Drew AF. Bleomycin-induced pulmonary fibrosis in fibrinogen-null mice. J Clin Invest 2000;106:1341-1350.
-
(2000)
J Clin Invest
, vol.106
, pp. 1341-1350
-
-
Hattori, N.1
Degen, J.L.2
Sisson, T.H.3
Liu, H.4
Moore, B.B.5
Pandrangi, R.G.6
Simon, R.H.7
Drew, A.F.8
-
33
-
-
0034493782
-
A total fibrinogen deficiency is compatible with the development of pulmonary fibrosis in mice
-
Ploplis VA, Wilberding J, McLennan L, Liang Z, Cornelissen I, DeFord ME, Rosen ED, Castellino FJ. A total fibrinogen deficiency is compatible with the development of pulmonary fibrosis in mice. Am J Pathol 2000;157:703-708.
-
(2000)
Am J Pathol
, vol.157
, pp. 703-708
-
-
Ploplis, V.A.1
Wilberding, J.2
McLennan, L.3
Liang, Z.4
Cornelissen, I.5
DeFord, M.E.6
Rosen, E.D.7
Castellino, F.J.8
-
34
-
-
0034795622
-
Direct thrombin inhibition reduces lung collagen, accumulation, and connective tissue growth factor mRNA levels in bleomycin-induced pulmonary fibrosis
-
Howell DC, Goldsack NR, Marshall RP, McAnulty RJ, Starke R, Purdy G, Laurent GJ, Chambers RC. Direct thrombin inhibition reduces lung collagen, accumulation, and connective tissue growth factor mRNA levels in bleomycin-induced pulmonary fibrosis. Am J Pathol 2001;159:1383-1395.
-
(2001)
Am J Pathol
, vol.159
, pp. 1383-1395
-
-
Howell, D.C.1
Goldsack, N.R.2
Marshall, R.P.3
McAnulty, R.J.4
Starke, R.5
Purdy, G.6
Laurent, G.J.7
Chambers, R.C.8
-
35
-
-
17844399243
-
Absence of proteinase-activated receptor-1 signaling affords protection from bleomycin-induced lung in flammation and fibrosis
-
Howell DC, Johns RH, Lasky JA, Shan B, Scotton CJ, Laurent GJ, Chambers RC. Absence of proteinase-activated receptor-1 signaling affords protection from bleomycin-induced lung in flammation and fibrosis. Am J Pathol 2005;166:1353-1365.
-
(2005)
Am J Pathol
, vol.166
, pp. 1353-1365
-
-
Howell, D.C.1
Johns, R.H.2
Lasky, J.A.3
Shan, B.4
Scotton, C.J.5
Laurent, G.J.6
Chambers, R.C.7
-
36
-
-
79955558187
-
Antiinflammatory and antifibrotic effects of the oral direct thrombin inhibitor dabigatran etexilate in a murine model of interstitial lung disease
-
Bogatkevich GS, Ludwicka-Bradley A, Nietert PJ, Akter T, van Ryn J, Silver RM. Antiinflammatory and antifibrotic effects of the oral direct thrombin inhibitor dabigatran etexilate in a murine model of interstitial lung disease. Arthritis Rheum 2011;63:1416-1425.
-
(2011)
Arthritis Rheum
, vol.63
, pp. 1416-1425
-
-
Bogatkevich, G.S.1
Ludwicka-Bradley, A.2
Nietert, P.J.3
Akter, T.4
Van Ryn, J.5
Silver, R.M.6
-
37
-
-
0036549755
-
Coagulation cascade proteases and tissue fibrosis
-
Chambers RC, Laurent GJ. Coagulation cascade proteases and tissue fibrosis. Biochem Soc Trans 2002;30:194-200.
-
(2002)
Biochem Soc Trans
, vol.30
, pp. 194-200
-
-
Chambers, R.C.1
Laurent, G.J.2
-
38
-
-
33745183811
-
Ligation of protease-activated receptor 1 enhances alpha(v)beta6 integrin-dependent TGF-beta activation and promotes acute lung injury
-
Jenkins RG, Su X, Su G, Scotton CJ, Camerer E, Laurent GJ, Davis GE, Chambers RC, Matthay MA, Sheppard D. Ligation of protease-activated receptor 1 enhances alpha(v)beta6 integrin-dependent TGF-beta activation and promotes acute lung injury. J Clin Invest 2006;116:1606-1614.
-
(2006)
J Clin Invest
, vol.116
, pp. 1606-1614
-
-
Jenkins, R.G.1
Su, X.2
Su, G.3
Scotton, C.J.4
Camerer, E.5
Laurent, G.J.6
Davis, G.E.7
Chambers, R.C.8
Matthay, M.A.9
Sheppard, D.10
-
40
-
-
84855942903
-
Metchnikoff's policemen: Macrophages in development, homeostasis and regeneration
-
Stefater JA III, Ren S, Lang RA, Duffield JS. Metchnikoff's policemen: macrophages in development, homeostasis and regeneration. Trends Mol Med 2011;17:743-752.
-
(2011)
Trends Mol Med
, vol.17
, pp. 743-752
-
-
Stefater, J.A.1
Ren, S.2
Lang, R.A.3
Duffield, J.S.4
-
41
-
-
80355131976
-
Protective and pathogenic functions of macrophage subsets
-
Murray PJ, Wynn TA. Protective and pathogenic functions of macrophage subsets. Nat Rev Immunol 2011;11:723-737.
-
(2011)
Nat Rev Immunol
, vol.11
, pp. 723-737
-
-
Murray, P.J.1
Wynn, T.A.2
-
42
-
-
84877064608
-
Macrophages and fibrosis: How resident and infiltrating mononuclear phagocytes orchestrate all phases of tissue injury and repair
-
Lech M, Anders HJ. Macrophages and fibrosis: how resident and infiltrating mononuclear phagocytes orchestrate all phases of tissue injury and repair. Biochim Biophys Acta 2013;1832:989-997.
-
(2013)
Biochim Biophys Acta
, vol.1832
, pp. 989-997
-
-
Lech, M.1
Anders, H.J.2
-
44
-
-
5444262511
-
Toll-like receptor control of the adaptive immune responses
-
Iwasaki A, Medzhitov R. Toll-like receptor control of the adaptive immune responses. Nat Immunol 2004;5:987-995.
-
(2004)
Nat Immunol
, vol.5
, pp. 987-995
-
-
Iwasaki, A.1
Medzhitov, R.2
-
45
-
-
84863702343
-
Mechanisms of fibrosis: Therapeutic translation for fibrotic disease
-
Wynn TA, Ramalingam TR. Mechanisms of fibrosis: therapeutic translation for fibrotic disease. Nat Med 2012;18:1028-1040.
-
(2012)
Nat Med
, vol.18
, pp. 1028-1040
-
-
Wynn, T.A.1
Ramalingam, T.R.2
-
46
-
-
84861394764
-
Prednisone, azathioprine, and N-acetylcysteine for pulmonary fibrosis
-
Raghu G, Anstrom KJ, King TE Jr, Lasky JA, Martinez FJ; Idiopathic Pulmonary Fibrosis Clinical Research Network. Prednisone, azathioprine, and N-acetylcysteine for pulmonary fibrosis. N Engl J Med 2012;366:1968-1977.
-
(2012)
N Engl J Med
, vol.366
, pp. 1968-1977
-
-
Raghu, G.1
Anstrom, K.J.2
King, T.E.3
Lasky, J.A.4
Martinez, F.J.5
Idiopathic Pulmonary Fibrosis Clinical Research Network6
-
47
-
-
35448988114
-
Molecular targets in pulmonary fibrosis: The myofibroblast in focus
-
Scotton CJ, Chambers RC. Molecular targets in pulmonary fibrosis: the myofibroblast in focus. Chest 2007;132:1311-1321.
-
(2007)
Chest
, vol.132
, pp. 1311-1321
-
-
Scotton, C.J.1
Chambers, R.C.2
-
48
-
-
33847392947
-
New developments in fibroblast and myofibroblast biology: Implications for fibrosis and scleroderma
-
Abraham DJ, Eckes B, Rajkumar V, Krieg T. New developments in fibroblast and myofibroblast biology: implications for fibrosis and scleroderma. Curr Rheumatol Rep 2007;9:136-143.
-
(2007)
Curr Rheumatol Rep
, vol.9
, pp. 136-143
-
-
Abraham, D.J.1
Eckes, B.2
Rajkumar, V.3
Krieg, T.4
-
49
-
-
13844270572
-
Tissue repair, contraction, and the myofibroblast
-
Desmoulière A, Chaponnier C, Gabbiani G. Tissue repair, contraction, and the myofibroblast. Wound Repair Regen 2005;13:7-12.
-
(2005)
Wound Repair Regen
, vol.13
, pp. 7-12
-
-
Desmoulière, A.1
Chaponnier, C.2
Gabbiani, G.3
-
51
-
-
36349003677
-
Transforming growth factor-beta and substrate stiffness regulate portal fibroblast activation in culture
-
Li Z, Dranoff JA, Chan EP, Uemura M, Sévigny J, Wells RG. Transforming growth factor-beta and substrate stiffness regulate portal fibroblast activation in culture. Hepatology 2007;46:1246-1256.
-
(2007)
Hepatology
, vol.46
, pp. 1246-1256
-
-
Li, Z.1
Dranoff, J.A.2
Chan, E.P.3
Uemura, M.4
Sévigny, J.5
Wells, R.G.6
-
52
-
-
84859117606
-
The mechanical memory of lung myofibroblasts
-
Balestrini JL, Chaudhry S, Sarrazy V, Koehler A, Hinz B. The mechanical memory of lung myofibroblasts. Integr Biol (Camb) 2012;4:410-421.
-
(2012)
Integr Biol (Camb)
, vol.4
, pp. 410-421
-
-
Balestrini, J.L.1
Chaudhry, S.2
Sarrazy, V.3
Koehler, A.4
Hinz, B.5
-
53
-
-
84865121019
-
Matrix stiffness-induced myofibroblast differentiation is mediated by intrinsic mechanotransduction
-
Huang X, Yang N, Fiore VF, Barker TH, Sun Y, Morris SW, Ding Q, Thannickal VJ, Zhou Y. Matrix stiffness-induced myofibroblast differentiation is mediated by intrinsic mechanotransduction. Am J Respir Cell Mol Biol 2012;47:340-348.
-
(2012)
Am J Respir Cell Mol Biol
, vol.47
, pp. 340-348
-
-
Huang, X.1
Yang, N.2
Fiore, V.F.3
Barker, T.H.4
Sun, Y.5
Morris, S.W.6
Ding, Q.7
Thannickal, V.J.8
Zhou, Y.9
-
54
-
-
37249044357
-
Myofibroblast contraction activates latent TGF-beta1 from the extracellular matrix
-
Wipff PJ, Rifkin DB, Meister JJ, Hinz B. Myofibroblast contraction activates latent TGF-beta1 from the extracellular matrix. J Cell Biol 2007;179:1311-1323.
-
(2007)
J Cell Biol
, vol.179
, pp. 1311-1323
-
-
Wipff, P.J.1
Rifkin, D.B.2
Meister, J.J.3
Hinz, B.4
-
55
-
-
77955914547
-
Feedback amplification of fibrosis through matrix stiffening and COX-2 suppression
-
Liu F, Mih JD, Shea BS, Kho AT, Sharif AS, Tager AM, Tschumperlin DJ. Feedback amplification of fibrosis through matrix stiffening and COX-2 suppression. J Cell Biol 2010;190:693-706.
-
(2010)
J Cell Biol
, vol.190
, pp. 693-706
-
-
Liu, F.1
Mih, J.D.2
Shea, B.S.3
Kho, A.T.4
Sharif, A.S.5
Tager, A.M.6
Tschumperlin, D.J.7
-
56
-
-
37149050014
-
Increased stiffness of the rat liver precedes matrix deposition: Implications for fibrosis
-
Georges PC, Hui JJ, Gombos Z, McCormick ME, Wang AY, Uemura M, Mick R, Janmey PA, Furth EE, Wells RG. Increased stiffness of the rat liver precedes matrix deposition: implications for fibrosis. Am J Physiol Gastrointest Liver Physiol 2007;293:G1147-G1154.
-
(2007)
Am J Physiol Gastrointest Liver Physiol
, vol.293
, pp. G1147-G1154
-
-
Georges, P.C.1
Hui, J.J.2
Gombos, Z.3
McCormick, M.E.4
Wang, A.Y.5
Uemura, M.6
Mick, R.7
Janmey, P.A.8
Furth, E.E.9
Wells, R.G.10
-
57
-
-
75949130829
-
Strategies for treating idiopathic pulmonary fibrosis
-
du Bois RM. Strategies for treating idiopathic pulmonary fibrosis. Nat Rev Drug Discov 2010;9:129-140.
-
(2010)
Nat Rev Drug Discov
, vol.9
, pp. 129-140
-
-
Du Bois, R.M.1
-
58
-
-
84881639762
-
Beyond the diagnosis of idiopathic pulmonary fibrosis; the growing role of systems biology and stratified medicine
-
Maher TM. Beyond the diagnosis of idiopathic pulmonary fibrosis; the growing role of systems biology and stratified medicine. Curr Opin Pulm Med 2013;19:460-465.
-
(2013)
Curr Opin Pulm Med
, vol.19
, pp. 460-465
-
-
Maher, T.M.1
-
59
-
-
76049083966
-
Reactive oxygen species, cellular redox systems, and apoptosis
-
Circu ML, Aw TY. Reactive oxygen species, cellular redox systems, and apoptosis. Free Radic Biol Med 2010;48:749-762.
-
(2010)
Free Radic Biol Med
, vol.48
, pp. 749-762
-
-
Circu, M.L.1
Aw, T.Y.2
-
61
-
-
0024578662
-
Glutathione deficiency in the epithelial lining fluid of the lower respiratory tract in idiopathic pulmonary fibrosis
-
Cantin AM, Hubbard RC, Crystal RG. Glutathione deficiency in the epithelial lining fluid of the lower respiratory tract in idiopathic pulmonary fibrosis. Am Rev Respir Dis 1989;139:370-372.
-
(1989)
Am Rev Respir Dis
, vol.139
, pp. 370-372
-
-
Cantin, A.M.1
Hubbard, R.C.2
Crystal, R.G.3
-
62
-
-
28244500027
-
Antioxidant therapy for idiopathic pulmonary fibrosis
-
Hunninghake GW. Antioxidant therapy for idiopathic pulmonary fibrosis. N Engl J Med 2005;353:2285-2287.
-
(2005)
N Engl J Med
, vol.353
, pp. 2285-2287
-
-
Hunninghake, G.W.1
-
63
-
-
28144459814
-
High-dose acetylcysteine in idiopathic pulmonary fibrosis
-
Demedts M, Behr J, Buhl R, Costabel U, Dekhuijzen R, Jansen HM, MacNee W, Thomeer M, Wallaert B, Laurent F, et al.; IFIGENIA Study Group. High-dose acetylcysteine in idiopathic pulmonary fibrosis. N Engl J Med 2005;353:2229-2242.
-
(2005)
N Engl J Med
, vol.353
, pp. 2229-2242
-
-
Demedts, M.1
Behr, J.2
Buhl, R.3
Costabel, U.4
Dekhuijzen, R.5
Jansen, H.M.6
MacNee, W.7
Thomeer, M.8
Wallaert, B.9
Laurent, F.10
-
64
-
-
84901746607
-
Randomized trial of acetylcysteine in idiopathic pulmonary fibrosis
-
Martinez FJ, de Andrade JA, Anstrom KJ, King TE Jr, Raghu G; Idiopathic Pulmonary Fibrosis Clinical Research Network. Randomized trial of acetylcysteine in idiopathic pulmonary fibrosis. N Engl J Med 2014;370:2093-2101.
-
(2014)
N Engl J Med
, vol.370
, pp. 2093-2101
-
-
Martinez, F.J.1
De Andrade, J.A.2
Anstrom, K.J.3
King, T.E.4
Raghu, G.5
Idiopathic Pulmonary Fibrosis Clinical Research Network6
-
65
-
-
30044449492
-
IL-13 signaling through the IL-13alpha2 receptor is involved in induction of TGF-beta1 production and fibrosis
-
Fichtner-Feigl S, Strober W, Kawakami K, Puri RK, Kitani A. IL-13 signaling through the IL-13alpha2 receptor is involved in induction of TGF-beta1 production and fibrosis. Nat Med 2006;12:99-106.
-
(2006)
Nat Med
, vol.12
, pp. 99-106
-
-
Fichtner-Feigl, S.1
Strober, W.2
Kawakami, K.3
Puri, R.K.4
Kitani, A.5
-
66
-
-
0037087365
-
IL-13-induced chemokine responses in the lung: Role of CCR2 in the pathogenesis of IL-13-induced inflammation and remodeling
-
Zhu Z, Ma B, Zheng T, Homer RJ, Lee CG, Charo IF, Noble P, Elias JA. IL-13-induced chemokine responses in the lung: role of CCR2 in the pathogenesis of IL-13-induced inflammation and remodeling. J Immunol 2002;168:2953-2962.
-
(2002)
J Immunol
, vol.168
, pp. 2953-2962
-
-
Zhu, Z.1
Ma, B.2
Zheng, T.3
Homer, R.J.4
Lee, C.G.5
Charo, I.F.6
Noble, P.7
Elias, J.A.8
-
67
-
-
0034764068
-
Interleukin-13 induces dramatically different transcriptional programs in three human airway cell types
-
Lee JH, Kaminski N, Dolganov G, Grunig G, Koth L, Solomon C, Erle DJ, Sheppard D. Interleukin-13 induces dramatically different transcriptional programs in three human airway cell types. Am J Respir Cell Mol Biol 2001;25:474-485.
-
(2001)
Am J Respir Cell Mol Biol
, vol.25
, pp. 474-485
-
-
Lee, J.H.1
Kaminski, N.2
Dolganov, G.3
Grunig, G.4
Koth, L.5
Solomon, C.6
Erle, D.J.7
Sheppard, D.8
-
68
-
-
48949117336
-
Hyper-responsiveness of IPF/UIP fibroblasts: Interplay between TGFbeta1, IL-13 and CCL2
-
Murray LA, Argentieri RL, Farrell FX, Bracht M, Sheng H, Whitaker B, Beck H, Tsui P, Cochlin K, Evanoff HL, et al. Hyper-responsiveness of IPF/UIP fibroblasts: interplay between TGFbeta1, IL-13 and CCL2. Int J Biochem Cell Biol 2008;40:2174-2182.
-
(2008)
Int J Biochem Cell Biol
, vol.40
, pp. 2174-2182
-
-
Murray, L.A.1
Argentieri, R.L.2
Farrell, F.X.3
Bracht, M.4
Sheng, H.5
Whitaker, B.6
Beck, H.7
Tsui, P.8
Cochlin, K.9
Evanoff, H.L.10
-
69
-
-
0031606459
-
Production of interleukin 13 by alveolar macrophages from normal and fibrotic lung
-
Hancock A, Armstrong L, Gama R, Millar A. Production of interleukin 13 by alveolar macrophages from normal and fibrotic lung. Am J Respir Cell Mol Biol 1998;18:60-65.
-
(1998)
Am J Respir Cell Mol Biol
, vol.18
, pp. 60-65
-
-
Hancock, A.1
Armstrong, L.2
Gama, R.3
Millar, A.4
-
70
-
-
79958297487
-
Antifibrotic activities of pirfenidone in animal models
-
Schaefer CJ, Ruhrmund DW, Pan L, Seiwert SD, Kossen K. Antifibrotic activities of pirfenidone in animal models. Eur Respir Rev 2011;20:85-97.
-
(2011)
Eur Respir Rev
, vol.20
, pp. 85-97
-
-
Schaefer, C.J.1
Ruhrmund, D.W.2
Pan, L.3
Seiwert, S.D.4
Kossen, K.5
-
71
-
-
77958165170
-
Pirfenidone in idiopathic pulmonary fibrosis
-
Maher TM. Pirfenidone in idiopathic pulmonary fibrosis. Drugs Today (Barc) 2010;46:473-482.
-
(2010)
Drugs Today (Barc)
, vol.46
, pp. 473-482
-
-
Maher, T.M.1
-
72
-
-
48149113955
-
Antifibrotic action of pirfenidone and prednisolone: Different effects on pulmonary cytokines and growth factors in bleomycin-induced murine pulmonary fibrosis
-
Oku H, Shimizu T, Kawabata T, Nagira M, Hikita I, Ueyama A, Matsushima S, Torii M, Arimura A. Antifibrotic action of pirfenidone and prednisolone: different effects on pulmonary cytokines and growth factors in bleomycin-induced murine pulmonary fibrosis. Eur J Pharmacol 2008;590:400-408.
-
(2008)
Eur J Pharmacol
, vol.590
, pp. 400-408
-
-
Oku, H.1
Shimizu, T.2
Kawabata, T.3
Nagira, M.4
Hikita, I.5
Ueyama, A.6
Matsushima, S.7
Torii, M.8
Arimura, A.9
-
73
-
-
84894278927
-
Pirfenidone inhibits fibrocyte accumulation in the lungs in bleomycin-induced murine pulmonary fibrosis
-
Inomata M, Kamio K, Azuma A, Matsuda K, Kokuho N, Miura Y, Hayashi H, Nei T, Fujita K, Saito Y, et al. Pirfenidone inhibits fibrocyte accumulation in the lungs in bleomycin-induced murine pulmonary fibrosis. Respir Res 2014;15:16.
-
(2014)
Respir Res
, vol.15
, pp. 16
-
-
Inomata, M.1
Kamio, K.2
Azuma, A.3
Matsuda, K.4
Kokuho, N.5
Miura, Y.6
Hayashi, H.7
Nei, T.8
Fujita, K.9
Saito, Y.10
-
74
-
-
0032917960
-
Effects of pirfenidone on procollagen gene expression at the transcriptional level in bleomycin hamster model of lung fibrosis
-
Iyer SN, Gurujeyalakshmi G, Giri SN. Effects of pirfenidone on procollagen gene expression at the transcriptional level in bleomycin hamster model of lung fibrosis. J Pharmacol Exp Ther 1999;289:211-218.
-
(1999)
J Pharmacol Exp Ther
, vol.289
, pp. 211-218
-
-
Iyer, S.N.1
Gurujeyalakshmi, G.2
Giri, S.N.3
-
75
-
-
0029318974
-
Dietary intake of pirfenidone ameliorates bleomycin-induced lung fibrosis in hamsters
-
Iyer SN, Wild JS, Schiedt MJ, Hyde DM, Margolin SB, Giri SN. Dietary intake of pirfenidone ameliorates bleomycin-induced lung fibrosis in hamsters. J Lab Clin Med 1995;125:779-785.
-
(1995)
J Lab Clin Med
, vol.125
, pp. 779-785
-
-
Iyer, S.N.1
Wild, J.S.2
Schiedt, M.J.3
Hyde, D.M.4
Margolin, S.B.5
Giri, S.N.6
-
76
-
-
33748470700
-
Pirfenidone modulates airway responsiveness, inflammation, and remodeling after repeated challenge
-
Hirano A, Kanehiro A, Ono K, Ito W, Yoshida A, Okada C, Nakashima H, Tanimoto Y, Kataoka M, Gelfand EW, et al. Pirfenidone modulates airway responsiveness, inflammation, and remodeling after repeated challenge. Am J Respir Cell Mol Biol 2006;35:366-377.
-
(2006)
Am J Respir Cell Mol Biol
, vol.35
, pp. 366-377
-
-
Hirano, A.1
Kanehiro, A.2
Ono, K.3
Ito, W.4
Yoshida, A.5
Okada, C.6
Nakashima, H.7
Tanimoto, Y.8
Kataoka, M.9
Gelfand, E.W.10
-
77
-
-
0032842405
-
Effects of pirfenidone on transforming growth factor-beta gene expression at the transcriptional level in bleomycin hamster model of lung fibrosis
-
Iyer SN, Gurujeyalakshmi G, Giri SN. Effects of pirfenidone on transforming growth factor-beta gene expression at the transcriptional level in bleomycin hamster model of lung fibrosis. J Pharmacol Exp Ther 1999;291:367-373.
-
(1999)
J Pharmacol Exp Ther
, vol.291
, pp. 367-373
-
-
Iyer, S.N.1
Gurujeyalakshmi, G.2
Giri, S.N.3
-
78
-
-
77951160564
-
Pirfenidone in idiopathic pulmonary fibrosis
-
Taniguchi H, Ebina M, Kondoh Y, Ogura T, Azuma A, Suga M, Taguchi Y, Takahashi H, Nakata K, Sato A, et al.; Pirfenidone Clinical Study Group in Japan. Pirfenidone in idiopathic pulmonary fibrosis. Eur Respir J 2010;35:821-829.
-
(2010)
Eur Respir J
, vol.35
, pp. 821-829
-
-
Taniguchi, H.1
Ebina, M.2
Kondoh, Y.3
Ogura, T.4
Azuma, A.5
Suga, M.6
Taguchi, Y.7
Takahashi, H.8
Nakata, K.9
Sato, A.10
-
79
-
-
79956341531
-
Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): Two randomised trials
-
Noble PW, Albera C, Bradford WZ, Costabel U, Glassberg MK, Kardatzke D, King TE Jr, Lancaster L, Sahn SA, Szwarcberg J, et al.; CAPACITY Study Group. Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials. Lancet 2011;377:1760-1769.
-
(2011)
Lancet
, vol.377
, pp. 1760-1769
-
-
Noble, P.W.1
Albera, C.2
Bradford, W.Z.3
Costabel, U.4
Glassberg, M.K.5
Kardatzke, D.6
King, T.E.7
Lancaster, L.8
Sahn, S.A.9
Szwarcberg, J.10
-
80
-
-
49649123154
-
BIBF 1120: Triple angiokinase inhibitor with sustained receptor blockade and good antitumor efficacy
-
Hilberg F, Roth GJ, Krssak M, Kautschitsch S, Sommergruber W, Tontsch-Grunt U, Garin-Chesa P, Bader G, Zoephel A, Quant J, et al. BIBF 1120: triple angiokinase inhibitor with sustained receptor blockade and good antitumor efficacy. Cancer Res 2008;68:4774-4782.
-
(2008)
Cancer Res
, vol.68
, pp. 4774-4782
-
-
Hilberg, F.1
Roth, G.J.2
Krssak, M.3
Kautschitsch, S.4
Sommergruber, W.5
Tontsch-Grunt, U.6
Garin-Chesa, P.7
Bader, G.8
Zoephel, A.9
Quant, J.10
-
81
-
-
84898792564
-
Antifibrotic and anti-inflammatory activity of the tyrosine kinase inhibitor nintedanib in experimental models of lung fibrosis
-
Wollin L, Maillet I, Quesniaux V, Holweg A, Ryffel B. Antifibrotic and anti-inflammatory activity of the tyrosine kinase inhibitor nintedanib in experimental models of lung fibrosis. J Pharmacol Exp Ther 2014;349:209-220.
-
(2014)
J Pharmacol Exp Ther
, vol.349
, pp. 209-220
-
-
Wollin, L.1
Maillet, I.2
Quesniaux, V.3
Holweg, A.4
Ryffel, B.5
-
82
-
-
25444467151
-
Growth factors in idiopathic pulmonary fibrosis: Relative roles
-
Allen JT, Spiteri MA. Growth factors in idiopathic pulmonary fibrosis: relative roles. Respir Res 2002;3:13.
-
(2002)
Respir Res
, vol.3
, pp. 13
-
-
Allen, J.T.1
Spiteri, M.A.2
-
83
-
-
0034086608
-
Lung overexpression of the vascular endothelial growth factor gene induces pulmonary edema
-
Kaner RJ, Ladetto JV, Singh R, Fukuda N, Matthay MA, Crystal RG. Lung overexpression of the vascular endothelial growth factor gene induces pulmonary edema. Am J Respir Cell Mol Biol 2000;22:657-664.
-
(2000)
Am J Respir Cell Mol Biol
, vol.22
, pp. 657-664
-
-
Kaner, R.J.1
Ladetto, J.V.2
Singh, R.3
Fukuda, N.4
Matthay, M.A.5
Crystal, R.G.6
-
84
-
-
84863798325
-
Angiogenesis in pulmonary fibrosis: Too much or not enough?
-
Hanumegowda C, Farkas L, Kolb M. Angiogenesis in pulmonary fibrosis: too much or not enough? Chest 2012;142:200-207.
-
(2012)
Chest
, vol.142
, pp. 200-207
-
-
Hanumegowda, C.1
Farkas, L.2
Kolb, M.3
-
85
-
-
2142646426
-
TGF-beta signaling and the fibrotic response
-
Leask A, Abraham DJ. TGF-beta signaling and the fibrotic response. FASEB J 2004;18:816-827.
-
(2004)
FASEB J
, vol.18
, pp. 816-827
-
-
Leask, A.1
Abraham, D.J.2
-
86
-
-
0028109801
-
Transforming growth factor beta in tissue fibrosis
-
Border WA, Noble NA. Transforming growth factor beta in tissue fibrosis. N Engl J Med 1994;331:1286-1292.
-
(1994)
N Engl J Med
, vol.331
, pp. 1286-1292
-
-
Border, W.A.1
Noble, N.A.2
-
87
-
-
0027425864
-
Effect of antibody to transforming growth factor beta on bleomycin induced accumulation of lung collagen in mice
-
Giri SN, Hyde DM, Hollinger MA. Effect of antibody to transforming growth factor beta on bleomycin induced accumulation of lung collagen in mice. Thorax 1993;48:959-966.
-
(1993)
Thorax
, vol.48
, pp. 959-966
-
-
Giri, S.N.1
Hyde, D.M.2
Hollinger, M.A.3
-
88
-
-
0030800795
-
Adenovector-mediated gene transfer of active transforming growth factor-beta1 induces prolonged severe fibrosis in rat lung
-
Sime PJ, Xing Z, Graham FL, Csaky KG, Gauldie J. Adenovector-mediated gene transfer of active transforming growth factor-beta1 induces prolonged severe fibrosis in rat lung. J Clin Invest 1997;100:768-776.
-
(1997)
J Clin Invest
, vol.100
, pp. 768-776
-
-
Sime, P.J.1
Xing, Z.2
Graham, F.L.3
Csaky, K.G.4
Gauldie, J.5
-
89
-
-
1242306647
-
The role of transforming growth factor beta in lung development and disease
-
Bartram U, Speer CP. The role of transforming growth factor beta in lung development and disease. Chest 2004;125:754-765.
-
(2004)
Chest
, vol.125
, pp. 754-765
-
-
Bartram, U.1
Speer, C.P.2
-
90
-
-
33845334175
-
Actions of tgf-beta as tumor suppressor and pro-metastatic factor in human cancer
-
Pardali K, Moustakas A. Actions of tgf-beta as tumor suppressor and pro-metastatic factor in human cancer. Biochim Biophys Acta 2007;1775:21-62.
-
(2007)
Biochim Biophys Acta
, vol.1775
, pp. 21-62
-
-
Pardali, K.1
Moustakas, A.2
-
91
-
-
0030908028
-
Latent transforming growth factor-beta: Structural features and mechanisms of activation
-
Munger JS, Harpel JG, Gleizes PE, Mazzieri R, Nunes I, Rifkin DB. Latent transforming growth factor-beta: structural features and mechanisms of activation. Kidney Int 1997;51:1376-1382.
-
(1997)
Kidney Int
, vol.51
, pp. 1376-1382
-
-
Munger, J.S.1
Harpel, J.G.2
Gleizes, P.E.3
Mazzieri, R.4
Nunes, I.5
Rifkin, D.B.6
-
92
-
-
0033524949
-
The integrin alpha v beta 6 binds and activates latent TGF beta 1: A mechanism for regulating pulmonary inflammation and fibrosis
-
Munger JS, Huang X, Kawakatsu H, Griffiths MJ, Dalton SL, Wu J, Pittet JF, Kaminski N, Garat C, Matthay MA, et al. The integrin alpha v beta 6 binds and activates latent TGF beta 1: a mechanism for regulating pulmonary inflammation and fibrosis. Cell 1999;96:319-328.
-
(1999)
Cell
, vol.96
, pp. 319-328
-
-
Munger, J.S.1
Huang, X.2
Kawakatsu, H.3
Griffiths, M.J.4
Dalton, S.L.5
Wu, J.6
Pittet, J.F.7
Kaminski, N.8
Garat, C.9
Matthay, M.A.10
-
93
-
-
38049002642
-
Partial inhibition of integrin alpha(v)beta6 prevents pulmonary fibrosis without exacerbating inflammation
-
Horan GS, Wood S, Ona V, Li DJ, Lukashev ME, Weinreb PH, Simon KJ, Hahm K, Allaire NE, Rinaldi NJ, et al. Partial inhibition of integrin alpha(v)beta6 prevents pulmonary fibrosis without exacerbating inflammation. Am J Respir Crit Care Med 2008;177:56-65.
-
(2008)
Am J Respir Crit Care Med
, vol.177
, pp. 56-65
-
-
Horan, G.S.1
Wood, S.2
Ona, V.3
Li, D.J.4
Lukashev, M.E.5
Weinreb, P.H.6
Simon, K.J.7
Hahm, K.8
Allaire, N.E.9
Rinaldi, N.J.10
-
94
-
-
37849008770
-
Inhibition of integrin alpha(v)beta6, an activator of latent transforming growth factor-beta, prevents radiation-induced lung fibrosis
-
Puthawala K, Hadjiangelis N, Jacoby SC, Bayongan E, Zhao Z, Yang Z, Devitt ML, Horan GS, Weinreb PH, Lukashev ME, et al. Inhibition of integrin alpha(v)beta6, an activator of latent transforming growth factor-beta, prevents radiation-induced lung fibrosis. Am J Respir Crit Care Med 2008;177:82-90.
-
(2008)
Am J Respir Crit Care Med
, vol.177
, pp. 82-90
-
-
Puthawala, K.1
Hadjiangelis, N.2
Jacoby, S.C.3
Bayongan, E.4
Zhao, Z.5
Yang, Z.6
Devitt, M.L.7
Horan, G.S.8
Weinreb, P.H.9
Lukashev, M.E.10
-
95
-
-
33845906843
-
All in the CCN family: Essential matricellular signaling modulators emerge from the bunker
-
Leask A, Abraham DJ. All in the CCN family: essential matricellular signaling modulators emerge from the bunker. J Cell Sci 2006;119:4803-4810.
-
(2006)
J Cell Sci
, vol.119
, pp. 4803-4810
-
-
Leask, A.1
Abraham, D.J.2
-
96
-
-
0036784690
-
Cyr61 and CTGF are molecular markers of bladder wall remodeling after outlet obstruction
-
Chaqour B, Whitbeck C, Han JS, Macarak E, Horan P, Chichester P, Levin R. Cyr61 and CTGF are molecular markers of bladder wall remodeling after outlet obstruction. Am J Physiol Endocrinol Metab 2002;283:E765-E774.
-
(2002)
Am J Physiol Endocrinol Metab
, vol.283
, pp. E765-E774
-
-
Chaqour, B.1
Whitbeck, C.2
Han, J.S.3
Macarak, E.4
Horan, P.5
Chichester, P.6
Levin, R.7
-
97
-
-
33746751471
-
Mechanical regulation of the Cyr61/ CCN1 and CTGF/CCN2 proteins
-
Chaqour B, Goppelt-Struebe M. Mechanical regulation of the Cyr61/ CCN1 and CTGF/CCN2 proteins. FEBS J 2006;273:3639-3649.
-
(2006)
FEBS J
, vol.273
, pp. 3639-3649
-
-
Chaqour, B.1
Goppelt-Struebe, M.2
-
98
-
-
0031225015
-
Connective tissue growth factor: A mediator of TGF-beta action on fibroblasts
-
Grotendorst GR. Connective tissue growth factor: a mediator of TGF-beta action on fibroblasts. Cytokine Growth Factor Rev 1997;8:171-179.
-
(1997)
Cytokine Growth Factor Rev
, vol.8
, pp. 171-179
-
-
Grotendorst, G.R.1
-
99
-
-
0033258181
-
Enhanced insulin-like growth factor binding protein-related protein 2 (connective tissue growth factor) expression in patients with idiopathic pulmonary fibrosis and pulmonary sarcoidosis
-
Allen JT, Knight RA, Bloor CA, Spiteri MA. Enhanced insulin-like growth factor binding protein-related protein 2 (connective tissue growth factor) expression in patients with idiopathic pulmonary fibrosis and pulmonary sarcoidosis. Am J Respir Cell Mol Biol 1999;21:693-700.
-
(1999)
Am J Respir Cell Mol Biol
, vol.21
, pp. 693-700
-
-
Allen, J.T.1
Knight, R.A.2
Bloor, C.A.3
Spiteri, M.A.4
-
100
-
-
0034883331
-
Type II alveolar epithelial cells and interstitial fibroblasts express connective tissue growth factor in IPF
-
Pan LH, Yamauchi K, Uzuki M, Nakanishi T, Takigawa M, Inoue H, Sawai T. Type II alveolar epithelial cells and interstitial fibroblasts express connective tissue growth factor in IPF. Eur Respir J 2001;17:1220-1227.
-
(2001)
Eur Respir J
, vol.17
, pp. 1220-1227
-
-
Pan, L.H.1
Yamauchi, K.2
Uzuki, M.3
Nakanishi, T.4
Takigawa, M.5
Inoue, H.6
Sawai, T.7
-
101
-
-
84865824802
-
Role of the lysophospholipid mediators lysophosphatidic acid and sphingosine 1-phosphate in lung fibrosis
-
Shea BS, Tager AM. Role of the lysophospholipid mediators lysophosphatidic acid and sphingosine 1-phosphate in lung fibrosis. Proc Am Thorac Soc 2012;9:102-110.
-
(2012)
Proc Am Thorac Soc
, vol.9
, pp. 102-110
-
-
Shea, B.S.1
Tager, A.M.2
-
102
-
-
38049091636
-
The lysophosphatidic acid receptor LPA1 links pulmonary fibrosis to lung injury by mediating fibroblast recruitment and vascular leak
-
Tager AM, LaCamera P, Shea BS, Campanella GS, Selman M, Zhao Z, Polosukhin V, Wain J, Karimi-Shah BA, Kim ND, et al. The lysophosphatidic acid receptor LPA1 links pulmonary fibrosis to lung injury by mediating fibroblast recruitment and vascular leak. Nat Med 2008;14:45-54.
-
(2008)
Nat Med
, vol.14
, pp. 45-54
-
-
Tager, A.M.1
LaCamera, P.2
Shea, B.S.3
Campanella, G.S.4
Selman, M.5
Zhao, Z.6
Polosukhin, V.7
Wain, J.8
Karimi-Shah, B.A.9
Kim, N.D.10
-
103
-
-
79955559412
-
Amelioration of dermal fibrosis by genetic deletion or pharmacologic antagonism of lysophosphatidic acid receptor 1 in a mouse model of scleroderma
-
Castelino FV, Seiders J, Bain G, Brooks SF, King CD, Swaney JS, Lorrain DS, Chun J, Luster AD, Tager AM. Amelioration of dermal fibrosis by genetic deletion or pharmacologic antagonism of lysophosphatidic acid receptor 1 in a mouse model of scleroderma. Arthritis Rheum 2011;63:1405-1415.
-
(2011)
Arthritis Rheum
, vol.63
, pp. 1405-1415
-
-
Castelino, F.V.1
Seiders, J.2
Bain, G.3
Brooks, S.F.4
King, C.D.5
Swaney, J.S.6
Lorrain, D.S.7
Chun, J.8
Luster, A.D.9
Tager, A.M.10
-
104
-
-
84877102431
-
LPA1- induced cytoskeleton reorganization drives fibrosis through CTGF-dependent fibroblast proliferation
-
Sakai N, Chun J, Duffield JS, Wada T, Luster AD, Tager AM. LPA1- induced cytoskeleton reorganization drives fibrosis through CTGF-dependent fibroblast proliferation. FASEB J 2013;27:1830-1846.
-
(2013)
FASEB J
, vol.27
, pp. 1830-1846
-
-
Sakai, N.1
Chun, J.2
Duffield, J.S.3
Wada, T.4
Luster, A.D.5
Tager, A.M.6
-
105
-
-
36849012184
-
LPA1 receptor activation promotes renal interstitial fibrosis
-
Pradère JP, Klein J, Grès S, Guigné C, Neau E, Valet P, Calise D, Chun J, Bascands JL, Saulnier-Blache JS, et al. LPA1 receptor activation promotes renal interstitial fibrosis. J Am Soc Nephrol 2007;18:3110-3118.
-
(2007)
J Am Soc Nephrol
, vol.18
, pp. 3110-3118
-
-
Pradère, J.P.1
Klein, J.2
Grès, S.3
Guigné, C.4
Neau, E.5
Valet, P.6
Calise, D.7
Chun, J.8
Bascands, J.L.9
Saulnier-Blache, J.S.10
-
106
-
-
80052933418
-
Idiopathic pulmonary fibrosis: The matrix is the message
-
J Kolb MR, Gauldie J. Idiopathic pulmonary fibrosis: the matrix is the message. Am J Respir Crit Care Med 2011;184:627-629.
-
(2011)
Am J Respir Crit Care Med
, vol.184
, pp. 627-629
-
-
J Kolb, M.R.1
Gauldie, J.2
-
107
-
-
77956425361
-
Allosteric inhibition of lysyl oxidase-like-2 impedes the development of a pathologic microenvironment
-
Barry-Hamilton V, Spangler R, Marshall D, McCauley S, Rodriguez HM, Oyasu M, Mikels A, Vaysberg M, Ghermazien H, Wai C, et al. Allosteric inhibition of lysyl oxidase-like-2 impedes the development of a pathologic microenvironment. Nat Med 2010;16:1009-1017.
-
(2010)
Nat Med
, vol.16
, pp. 1009-1017
-
-
Barry-Hamilton, V.1
Spangler, R.2
Marshall, D.3
McCauley, S.4
Rodriguez, H.M.5
Oyasu, M.6
Mikels, A.7
Vaysberg, M.8
Ghermazien, H.9
Wai, C.10
-
108
-
-
27144547143
-
Pulmonary hypertension in patients with idiopathic pulmonary fibrosis
-
Nadrous HF, Pellikka PA, Krowka MJ, Swanson KL, Chaowalit N, Decker PA, Ryu JH. Pulmonary hypertension in patients with idiopathic pulmonary fibrosis. Chest 2005;128:2393-2399.
-
(2005)
Chest
, vol.128
, pp. 2393-2399
-
-
Nadrous, H.F.1
Pellikka, P.A.2
Krowka, M.J.3
Swanson, K.L.4
Chaowalit, N.5
Decker, P.A.6
Ryu, J.H.7
-
109
-
-
84455201657
-
Gastroesophageal reflux therapy is associated with longer survival in patients with idiopathic pulmonary fibrosis
-
Lee JS, Ryu JH, Elicker BM, Lydell CP, Jones KD, Wolters PJ, King TE Jr, Collard HR. Gastroesophageal reflux therapy is associated with longer survival in patients with idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2011;184:1390-1394.
-
(2011)
Am J Respir Crit Care Med
, vol.184
, pp. 1390-1394
-
-
Lee, J.S.1
Ryu, J.H.2
Elicker, B.M.3
Lydell, C.P.4
Jones, K.D.5
Wolters, P.J.6
King, T.E.7
Collard, H.R.8
-
110
-
-
84888646149
-
Obstructive sleep apnea is common in patients with interstitial lung disease
-
Pihtili A, Bingol Z, Kiyan E, Cuhadaroglu C, Issever H, Gulbaran Z. Obstructive sleep apnea is common in patients with interstitial lung disease. Sleep Breath 2013;17:1281-1288.
-
(2013)
Sleep Breath
, vol.17
, pp. 1281-1288
-
-
Pihtili, A.1
Bingol, Z.2
Kiyan, E.3
Cuhadaroglu, C.4
Issever, H.5
Gulbaran, Z.6
-
111
-
-
30744455313
-
High prevalence of abnormal acid gastro-oesophageal reflux in idiopathic pulmonary fibrosis
-
Raghu G, Freudenberger TD, Yang S, Curtis JR, Spada C, Hayes J, Sillery JK, Pope CE II, Pellegrini CA. High prevalence of abnormal acid gastro-oesophageal reflux in idiopathic pulmonary fibrosis. Eur Respir J 2006;27:136-142.
-
(2006)
Eur Respir J
, vol.27
, pp. 136-142
-
-
Raghu, G.1
Freudenberger, T.D.2
Yang, S.3
Curtis, J.R.4
Spada, C.5
Hayes, J.6
Sillery, J.K.7
Pope, C.E.8
Pellegrini, C.A.9
-
112
-
-
84887263711
-
Gastro-oesophageal reflux and gastric aspiration in idiopathic pulmonary fibrosis patients
-
Savarino E, Carbone R, Marabotto E, Furnari M, Sconfienza L, Ghio M, Zentilin P, Savarino V. Gastro-oesophageal reflux and gastric aspiration in idiopathic pulmonary fibrosis patients. Eur Respir J 2013;42:1322-1331.
-
(2013)
Eur Respir J
, vol.42
, pp. 1322-1331
-
-
Savarino, E.1
Carbone, R.2
Marabotto, E.3
Furnari, M.4
Sconfienza, L.5
Ghio, M.6
Zentilin, P.7
Savarino, V.8
-
113
-
-
84863012828
-
Bronchoalveolar lavage pepsin in acute exacerbation of idiopathic pulmonary fibrosis
-
Lee JS, Song JW, Wolters PJ, Elicker BM, King TE Jr, Kim DS, Collard HR. Bronchoalveolar lavage pepsin in acute exacerbation of idiopathic pulmonary fibrosis. Eur Respir J 2012;39:352-358.
-
(2012)
Eur Respir J
, vol.39
, pp. 352-358
-
-
Lee, J.S.1
Song, J.W.2
Wolters, P.J.3
Elicker, B.M.4
King, T.E.5
Kim, D.S.6
Collard, H.R.7
-
114
-
-
33645124084
-
Sole treatment of acid gastroesophageal reflux in idiopathic pulmonary fibrosis: A case series
-
Raghu G, Yang ST, Spada C, Hayes J, Pellegrini CA. Sole treatment of acid gastroesophageal reflux in idiopathic pulmonary fibrosis: a case series. Chest 2006;129:794-800.
-
(2006)
Chest
, vol.129
, pp. 794-800
-
-
Raghu, G.1
Yang, S.T.2
Spada, C.3
Hayes, J.4
Pellegrini, C.A.5
-
115
-
-
31044453819
-
Laparoscopic fundoplication in patients with end-stage lung disease awaiting transplantation
-
Linden PA, Gilbert RJ, Yeap BY, Boyle K, Deykin A, Jaklitsch MT, Sugarbaker DJ, Bueno R. Laparoscopic fundoplication in patients with end-stage lung disease awaiting transplantation. J Thorac Cardiovasc Surg 2006;131:438-446.
-
(2006)
J Thorac Cardiovasc Surg
, vol.131
, pp. 438-446
-
-
Linden, P.A.1
Gilbert, R.J.2
Yeap, B.Y.3
Boyle, K.4
Deykin, A.5
Jaklitsch, M.T.6
Sugarbaker, D.J.7
Bueno, R.8
-
116
-
-
80053056245
-
Antireflux surgery preserves lung function in patients with gastroesophageal reflux disease and end-stage lung disease before and after lung transplantation
-
Hoppo T, Jarido V, Pennathur A, Morrell M, Crespo M, Shigemura N, Bermudez C, Hunter JG, Toyoda Y, Pilewski J, et al. Antireflux surgery preserves lung function in patients with gastroesophageal reflux disease and end-stage lung disease before and after lung transplantation. Arch Surg 2011;146:1041-1047.
-
(2011)
Arch Surg
, vol.146
, pp. 1041-1047
-
-
Hoppo, T.1
Jarido, V.2
Pennathur, A.3
Morrell, M.4
Crespo, M.5
Shigemura, N.6
Bermudez, C.7
Hunter, J.G.8
Toyoda, Y.9
Pilewski, J.10
-
117
-
-
84881367867
-
Anti-acid treatment and disease progression in idiopathic pulmonary fibrosis: An analysis of data from three randomised controlled trials
-
Lee JS, Collard HR, Anstrom KJ, Martinez FJ, Noth I, Roberts RS, Yow E, Raghu G; IPFnet Investigators. Anti-acid treatment and disease progression in idiopathic pulmonary fibrosis: an analysis of data from three randomised controlled trials. Lancet Respir Med 2013;1:369-376.
-
(2013)
Lancet Respir Med
, vol.1
, pp. 369-376
-
-
Lee, J.S.1
Collard, H.R.2
Anstrom, K.J.3
Martinez, F.J.4
Noth, I.5
Roberts, R.S.6
Yow, E.7
Raghu, G.8
-
118
-
-
70049102004
-
Obstructive sleep apnea is common in idiopathic pulmonary fibrosis
-
Lancaster LH, Mason WR, Parnell JA, Rice TW, Loyd JE, Milstone AP, Collard HR, Malow BA. Obstructive sleep apnea is common in idiopathic pulmonary fibrosis. Chest 2009;136:772-778.
-
(2009)
Chest
, vol.136
, pp. 772-778
-
-
Lancaster, L.H.1
Mason, W.R.2
Parnell, J.A.3
Rice, T.W.4
Loyd, J.E.5
Milstone, A.P.6
Collard, H.R.7
Malow, B.A.8
-
119
-
-
79955468654
-
How common is sleep-disordered breathing in patients with idiopathic pulmonary fibrosis?
-
Mermigkis C, Stagaki E, Tryfon S, Schiza S, Amfilochiou A, Polychronopoulos V, Panagou P, Galanis N, Kallianos A, Mermigkis D, et al. How common is sleep-disordered breathing in patients with idiopathic pulmonary fibrosis? Sleep Breath 2010;14:387-390.
-
(2010)
Sleep Breath
, vol.14
, pp. 387-390
-
-
Mermigkis, C.1
Stagaki, E.2
Tryfon, S.3
Schiza, S.4
Amfilochiou, A.5
Polychronopoulos, V.6
Panagou, P.7
Galanis, N.8
Kallianos, A.9
Mermigkis, D.10
-
120
-
-
78349290044
-
Inspiratory resistive breathing induces acute lung injury
-
Toumpanakis D, Kastis GA, Zacharatos P, Sigala I, Michailidou T, Kouvela M, Glynos C, Divangahi M, Roussos C, Theocharis SE, et al. Inspiratory resistive breathing induces acute lung injury. Am J Respir Crit Care Med 2010;182:1129-1136.
-
(2010)
Am J Respir Crit Care Med
, vol.182
, pp. 1129-1136
-
-
Toumpanakis, D.1
Kastis, G.A.2
Zacharatos, P.3
Sigala, I.4
Michailidou, T.5
Kouvela, M.6
Glynos, C.7
Divangahi, M.8
Roussos, C.9
Theocharis, S.E.10
-
121
-
-
84860544899
-
Is obstructive sleep apnea a cause of idiopathic pulmonary fibrosis?
-
author reply 470
-
Lederer DJ, Jelic S, Bhattacharya J, Basner RC. Is obstructive sleep apnea a cause of idiopathic pulmonary fibrosis? Arch Pathol Lab Med 2012;136:470, author reply 470.
-
(2012)
Arch Pathol Lab Med
, vol.136
, pp. 470
-
-
Lederer, D.J.1
Jelic, S.2
Bhattacharya, J.3
Basner, R.C.4
-
122
-
-
84880000480
-
Sleep oxygen desaturation predicts survival in idiopathic pulmonary fibrosis
-
Kolilekas L, Manali E, Vlami KA, Lyberopoulos P, Triantafillidou C, Kagouridis K, Baou K, Gyftopoulos S, Vougas KN, Karakatsani A, et al. Sleep oxygen desaturation predicts survival in idiopathic pulmonary fibrosis. J Clin Sleep Med 2013;9:593-601.
-
(2013)
J Clin Sleep Med
, vol.9
, pp. 593-601
-
-
Kolilekas, L.1
Manali, E.2
Vlami, K.A.3
Lyberopoulos, P.4
Triantafillidou, C.5
Kagouridis, K.6
Baou, K.7
Gyftopoulos, S.8
Vougas, K.N.9
Karakatsani, A.10
-
123
-
-
0037364372
-
Echocardiographic assessment of pulmonary hypertension in patients with advanced lung disease
-
Arcasoy SM, Christie JD, Ferrari VA, Sutton MS, Zisman DA, Blumenthal NP, Pochettino A, Kotloff RM. Echocardiographic assessment of pulmonary hypertension in patients with advanced lung disease. Am J Respir Crit Care Med 2003;167:735-740.
-
(2003)
Am J Respir Crit Care Med
, vol.167
, pp. 735-740
-
-
Arcasoy, S.M.1
Christie, J.D.2
Ferrari, V.A.3
Sutton, M.S.4
Zisman, D.A.5
Blumenthal, N.P.6
Pochettino, A.7
Kotloff, R.M.8
-
124
-
-
33645118315
-
Prevalence and outcomes of pulmonary arterial hypertension in advanced idiopathic pulmonary fibrosis
-
Lettieri CJ, Nathan SD, Barnett SD, Ahmad S, Shorr AF. Prevalence and outcomes of pulmonary arterial hypertension in advanced idiopathic pulmonary fibrosis. Chest 2006;129:746-752.
-
(2006)
Chest
, vol.129
, pp. 746-752
-
-
Lettieri, C.J.1
Nathan, S.D.2
Barnett, S.D.3
Ahmad, S.4
Shorr, A.F.5
-
125
-
-
79951844263
-
Clinical course and prediction of survival in idiopathic pulmonary fibrosis
-
Ley B, Collard HR, King TE Jr. Clinical course and prediction of survival in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2011;183:431-440.
-
(2011)
Am J Respir Crit Care Med
, vol.183
, pp. 431-440
-
-
Ley, B.1
Collard, H.R.2
King, T.E.3
-
126
-
-
34247618238
-
Idiopathic pulmonary fibrosis and pulmonary hypertension: Connecting the dots
-
Nathan SD, Noble PW, Tuder RM. Idiopathic pulmonary fibrosis and pulmonary hypertension: connecting the dots. Am J Respir Crit Care Med 2007;175:875-880.
-
(2007)
Am J Respir Crit Care Med
, vol.175
, pp. 875-880
-
-
Nathan, S.D.1
Noble, P.W.2
Tuder, R.M.3
-
127
-
-
80051557093
-
Pulmonary hypertension and idiopathic pulmonary fibrosis: A tale of angiogenesis, apoptosis, and growth factors
-
Farkas L, Gauldie J, Voelkel NF, Kolb M. Pulmonary hypertension and idiopathic pulmonary fibrosis: a tale of angiogenesis, apoptosis, and growth factors. Am J Respir Cell Mol Biol 2011;45:1-15.
-
(2011)
Am J Respir Cell Mol Biol
, vol.45
, pp. 1-15
-
-
Farkas, L.1
Gauldie, J.2
Voelkel, N.F.3
Kolb, M.4
-
128
-
-
79957518453
-
A key role for NOX4 in epithelial cell death during development of lung fibrosis
-
Carnesecchi S, Deffert C, Donati Y, Basset O, Hinz B, Preynat-Seauve O, Guichard C, Arbiser JL, Banfi B, Pache JC, et al. A key role for NOX4 in epithelial cell death during development of lung fibrosis. Antioxid Redox Signal 2011;15:607-619.
-
(2011)
Antioxid Redox Signal
, vol.15
, pp. 607-619
-
-
Carnesecchi, S.1
Deffert, C.2
Donati, Y.3
Basset, O.4
Hinz, B.5
Preynat-Seauve, O.6
Guichard, C.7
Arbiser, J.L.8
Banfi, B.9
Pache, J.C.10
-
129
-
-
69949114515
-
NADPH oxidase-4 mediates myofibroblast activation and fibrogenic responses to lung injury
-
Hecker L, Vittal R, Jones T, Jagirdar R, Luckhardt TR, Horowitz JC, Pennathur S, Martinez FJ, Thannickal VJ. NADPH oxidase-4 mediates myofibroblast activation and fibrogenic responses to lung injury. Nat Med 2009;15:1077-1081.
-
(2009)
Nat Med
, vol.15
, pp. 1077-1081
-
-
Hecker, L.1
Vittal, R.2
Jones, T.3
Jagirdar, R.4
Luckhardt, T.R.5
Horowitz, J.C.6
Pennathur, S.7
Martinez, F.J.8
Thannickal, V.J.9
-
130
-
-
84899103689
-
Reversal of persistent fibrosis in aging by targeting Nox4-Nrf2 redox imbalance
-
Hecker L, Logsdon NJ, Kurundkar D, Kurundkar A, Bernard K, Hock T, Meldrum E, Sanders YY, Thannickal VJ. Reversal of persistent fibrosis in aging by targeting Nox4-Nrf2 redox imbalance. Sci Transl Med 2014;6:231ra247.
-
(2014)
Sci Transl Med
, vol.6
, pp. 231ra247
-
-
Hecker, L.1
Logsdon, N.J.2
Kurundkar, D.3
Kurundkar, A.4
Bernard, K.5
Hock, T.6
Meldrum, E.7
Sanders, Y.Y.8
Thannickal, V.J.9
-
131
-
-
84887996436
-
Recombinant human serum amyloid P in healthy volunteers and patients with pulmonary fibrosis
-
Dillingh MR, van den Blink B, Moerland M, van Dongen MG, Levi M, Kleinjan A, Wijsenbeek MS, Lupher ML Jr, Harper DM, Getsy JA, et al. Recombinant human serum amyloid P in healthy volunteers and patients with pulmonary fibrosis. Pulm Pharmacol Ther 2013;26:672-676.
-
(2013)
Pulm Pharmacol Ther
, vol.26
, pp. 672-676
-
-
Dillingh, M.R.1
Van Den Blink, B.2
Moerland, M.3
Van Dongen, M.G.4
Levi, M.5
Kleinjan, A.6
Wijsenbeek, M.S.7
Lupher, M.L.8
Harper, D.M.9
Getsy, J.A.10
-
132
-
-
84884876178
-
Adult stem cells for chronic lung diseases
-
Mora AL, Rojas M. Adult stem cells for chronic lung diseases. Respirology 2013;18:1041-1046.
-
(2013)
Respirology
, vol.18
, pp. 1041-1046
-
-
Mora, A.L.1
Rojas, M.2
-
133
-
-
84872772689
-
Mesenchymal stem cells promote alveolar epithelial cell wound repair in vitro through distinct migratory and paracrine mechanisms
-
Akram KM, Samad S, Spiteri MA, Forsyth NR. Mesenchymal stem cells promote alveolar epithelial cell wound repair in vitro through distinct migratory and paracrine mechanisms. Respir Res 2013;14:9.
-
(2013)
Respir Res
, vol.14
, pp. 9
-
-
Akram, K.M.1
Samad, S.2
Spiteri, M.A.3
Forsyth, N.R.4
-
134
-
-
84863450246
-
A placebo-controlled randomized trial of warfarin in idiopathic pulmonary fibrosis
-
Noth I, Anstrom KJ, Calvert SB, de Andrade J, Flaherty KR, Glazer C, Kaner RJ, Olman MA; Idiopathic Pulmonary Fibrosis Clinical Research Network (IPFnet). A placebo-controlled randomized trial of warfarin in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2012;186:88-95.
-
(2012)
Am J Respir Crit Care Med
, vol.186
, pp. 88-95
-
-
Noth, I.1
Anstrom, K.J.2
Calvert, S.B.3
De Andrade, J.4
Flaherty, K.R.5
Glazer, C.6
Kaner, R.J.7
Olman, M.A.8
Idiopathic Pulmonary Fibrosis Clinical Research Network (IPFnet)9
-
135
-
-
37849012578
-
BUILD-1: A randomized placebo-controlled trial of bosentan in idiopathic pulmonary fibrosis
-
King TE Jr, Behr J, Brown KK, du Bois RM, Lancaster L, de Andrade JA, Stähler G, Leconte I, Roux S, Raghu G. BUILD-1: a randomized placebo-controlled trial of bosentan in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2008;177:75-81.
-
(2008)
Am J Respir Crit Care Med
, vol.177
, pp. 75-81
-
-
King, T.E.1
Behr, J.2
Brown, K.K.3
Du Bois, R.M.4
Lancaster, L.5
De Andrade, J.A.6
Stähler, G.7
Leconte, I.8
Roux, S.9
Raghu, G.10
-
136
-
-
80051566676
-
BUILD-3: A randomized, controlled trial of bosentan in idiopathic pulmonary fibrosis
-
King TE Jr, Brown KK, Raghu G, du Bois RM, Lynch DA, Martinez F, Valeyre D, Leconte I, Morganti A, Roux S, et al. BUILD-3: a randomized, controlled trial of bosentan in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2011;184:92-99.
-
(2011)
Am J Respir Crit Care Med
, vol.184
, pp. 92-99
-
-
King, T.E.1
Brown, K.K.2
Raghu, G.3
Du Bois, R.M.4
Lynch, D.A.5
Martinez, F.6
Valeyre, D.7
Leconte, I.8
Morganti, A.9
Roux, S.10
-
137
-
-
84888166435
-
Macitentan for the treatment of idiopathic pulmonary fibrosis: The randomised controlled MUSIC trial
-
Raghu G, Million-Rousseau R, Morganti A, Perchenet L, Behr J; MUSIC Study Group. Macitentan for the treatment of idiopathic pulmonary fibrosis: the randomised controlled MUSIC trial. Eur Respir J 2013;42:1622-1632.
-
(2013)
Eur Respir J
, vol.42
, pp. 1622-1632
-
-
Raghu, G.1
Million-Rousseau, R.2
Morganti, A.3
Perchenet, L.4
Behr, J.5
-
138
-
-
84877297353
-
Treatment of idiopathic pulmonary fibrosis with ambrisentan: A parallel, randomized trial
-
Raghu G, Behr J, Brown KK, Egan JJ, Kawut SM, Flaherty KR, Martinez FJ, Nathan SD, Wells AU, Collard HR, et al.; ARTEMIS-IPF Investigators. Treatment of idiopathic pulmonary fibrosis with ambrisentan: a parallel, randomized trial. Ann Intern Med 2013;158:641-649.
-
(2013)
Ann Intern Med
, vol.158
, pp. 641-649
-
-
Raghu, G.1
Behr, J.2
Brown, K.K.3
Egan, J.J.4
Kawut, S.M.5
Flaherty, K.R.6
Martinez, F.J.7
Nathan, S.D.8
Wells, A.U.9
Collard, H.R.10
-
139
-
-
0345824715
-
A placebo-controlled trial of interferon gamma-1b in patients with idiopathic pulmonary fibrosis
-
Raghu G, Brown KK, Bradford WZ, Starko K, Noble PW, Schwartz DA, King TE Jr; Idiopathic Pulmonary Fibrosis Study Group. A placebo-controlled trial of interferon gamma-1b in patients with idiopathic pulmonary fibrosis. N Engl J Med 2004;350:125-133.
-
(2004)
N Engl J Med
, vol.350
, pp. 125-133
-
-
Raghu, G.1
Brown, K.K.2
Bradford, W.Z.3
Starko, K.4
Noble, P.W.5
Schwartz, D.A.6
King, T.E.7
-
140
-
-
67650349068
-
Effect of interferon gamma-1b on survival in patients with idiopathic pulmonary fibrosis (INSPIRE): A multicentre, randomised, placebo-controlled trial
-
King TE Jr, Albera C, Bradford WZ, Costabel U, Hormel P, Lancaster L, Noble PW, Sahn SA, Szwarcberg J, Thomeer M, et al.; INSPIRE Study Group. Effect of interferon gamma-1b on survival in patients with idiopathic pulmonary fibrosis (INSPIRE): a multicentre, randomised, placebo-controlled trial. Lancet 2009;374:222-228.
-
(2009)
Lancet
, vol.374
, pp. 222-228
-
-
King, T.E.1
Albera, C.2
Bradford, W.Z.3
Costabel, U.4
Hormel, P.5
Lancaster, L.6
Noble, P.W.7
Sahn, S.A.8
Szwarcberg, J.9
Thomeer, M.10
-
141
-
-
77956640423
-
A controlled trial of sildenafil in advanced idiopathic pulmonary fibrosis
-
Zisman DA, Schwarz M, Anstrom KJ, Collard HR, Flaherty KR, Hunninghake GW; Idiopathic Pulmonary Fibrosis Clinical Research Network. A controlled trial of sildenafil in advanced idiopathic pulmonary fibrosis. N Engl J Med 2010;363:620-628.
-
(2010)
N Engl J Med
, vol.363
, pp. 620-628
-
-
Zisman, D.A.1
Schwarz, M.2
Anstrom, K.J.3
Collard, H.R.4
Flaherty, K.R.5
Hunninghake, G.W.6
Idiopathic Pulmonary Fibrosis Clinical Research Network7
-
142
-
-
77749324295
-
Imatinib treatment for idiopathic pulmonary fibrosis: Randomized placebo-controlled trial results
-
Daniels CE, Lasky JA, Limper AH, Mieras K, Gabor E, Schroeder DR; Imatinib-IPF Study Investigators. Imatinib treatment for idiopathic pulmonary fibrosis: randomized placebo-controlled trial results. Am J Respir Crit Care Med 2010;181:604-610.
-
(2010)
Am J Respir Crit Care Med
, vol.181
, pp. 604-610
-
-
Daniels, C.E.1
Lasky, J.A.2
Limper, A.H.3
Mieras, K.4
Gabor, E.5
Schroeder, D.R.6
-
143
-
-
84860320360
-
Octreotide treatment of idiopathic pulmonary fibrosis: A proof-of-concept study
-
Crestani B, Chapron J, Wallaert B, Bergot E, Delaval P, Israel-Biet D, Lacronique J, Monnet I, Reynaud-Gaubert M, Tazi A, et al. Octreotide treatment of idiopathic pulmonary fibrosis: a proof-of-concept study. Eur Respir J 2012;39:772-775.
-
(2012)
Eur Respir J
, vol.39
, pp. 772-775
-
-
Crestani, B.1
Chapron, J.2
Wallaert, B.3
Bergot, E.4
Delaval, P.5
Israel-Biet, D.6
Lacronique, J.7
Monnet, I.8
Reynaud-Gaubert, M.9
Tazi, A.10
-
144
-
-
55549147184
-
Treatment of idiopathic pulmonary fibrosis with etanercept: An exploratory, placebo-controlled trial
-
Raghu G, Brown KK, Costabel U, Cottin V, du Bois RM, Lasky JA, Thomeer M, Utz JP, Khandker RK, McDermott L, et al. Treatment of idiopathic pulmonary fibrosis with etanercept: an exploratory, placebo-controlled trial. Am J Respir Crit Care Med 2008;178:948-955.
-
(2008)
Am J Respir Crit Care Med
, vol.178
, pp. 948-955
-
-
Raghu, G.1
Brown, K.K.2
Costabel, U.3
Cottin, V.4
Du Bois, R.M.5
Lasky, J.A.6
Thomeer, M.7
Utz, J.P.8
Khandker, R.K.9
McDermott, L.10
-
145
-
-
84928982821
-
A phase II, randomized, double-blind, placebo-controlled, parallel-group, dose-ranging study of the safety and efficacy of CNTO 888 (carlumab) in patients with idiopathic pulmonary fibrosis
-
[abstract]
-
Raghu G, Martinez FJ, Brown KK, Costabel U, Cottin V, Well AU, Lancaster L, Gibson KF, Haddad T, Agarwal P, et al. A phase II, randomized, double-blind, placebo-controlled, parallel-group, dose-ranging study of the safety and efficacy of CNTO 888 (carlumab) in patients with idiopathic pulmonary fibrosis [abstract]. Am J Respir Crit Care Med 2013;187:A3376.
-
(2013)
Am J Respir Crit Care Med
, vol.187
, pp. A3376
-
-
Raghu, G.1
Martinez, F.J.2
Brown, K.K.3
Costabel, U.4
Cottin, V.5
Well, A.U.6
Lancaster, L.7
Gibson, K.F.8
Haddad, T.9
Agarwal, P.10
|